CSI Market
Sign In | Register

Adverum Biotechnologies Inc (ADVM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ADVM Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Adverum Biotechnologies Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Assets
Cash & cash equivalent26.06
Short-term Investments, Total0.00
Cash & Short-term Investments26.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.85
Total Current Assets28.91
Equipment/Property/Plant Net10.46
Deferred Rent Receivables, Net AS0.00
Other Assets, Noncurrent33.00
Operating Lease Right Of Use Asset29.03
Restricted Cash Noncurrent1.98
Total Assets72.40
Liabilities
Accounts Payable, Current AC12.46
Other Liabilities, Current32.29
Total Current Liabilities44.75
Total Long-term Debt0.00
Other liabilities, Noncurrent83.31
Accrued Expenses And Other Current Liabilities26.48
Operating Lease Liability Noncurrent83.13
Total Liabilities128.05
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,155.60
Retained Earnings / Accumulated Deficit-1,210.81
Other Equity-0.44
Common Stockholder's Equity-55.65
Total Stockholder's Equity-55.65
Liabilities & Stockholder's Equity72.40
4 historic quarters locked

Sign in to unlock the full Adverum Biotechnologies Inc balance sheet history.

Sign In Create Free Account

About Adverum Biotechnologies Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250930)
  • Filed with the SEC: November 12, 2025
  • Source: advm-20250930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-25-051593

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.